Improving patient outcomes through tailored, personalised care
Closed Loop Medicine improves drug effectiveness and patient outcomes through the development of a safe, protectable and scalable product solution that combines dose-optimized drug therapy with digital care.
Why it matters
Medical costs due to non-optimised medication therapy are estimated at USD 530 billion in the US annually.
Too many patients, particularly those affected by chronic disease, fail to gain any benefit from taking pills and tend to suffer a number of negative side-effects.
The outcomes are suboptimal health outcomes and inefficient use of resources by the healthcare system.
Impact KPIs
The data below shows the year-on-year change in impact KPIs for CLM (updated 2022).
+9%
number of patients supported through fine stage clinical studies
+13%
number of medical conditions addressable by Closed Loop Medicine’s personalised drug+digital approach
This app is like an angel on my shoulder.”
Clinical trial patient
This is an important study in that it allows patients and physicians to collect real-world data to help better inform treatment decisions and monitor patient outcomes. We can personalise treatment for the individual at a population scale.”
Dr David Collier, Queen Mary University of London
Dr Hakim Yadi
CEO
Closed Loop Medicine
Read morePrecision medicine, where healthcare treatments are tailored to the individual has, until now, only been applied to a handful of medical conditions. What if it could be applied more widely?”
